A new study is looking at a gene mutation (MYBPC3), which affects up to 8 percent of people from India, Pakistan, Bangladesh and other South Asian countries, with the hope of developing new treatment or prevention strategies. An estimated 55 million people of South Asian descent worldwide, including 200,000 people in the United States, carry […]
Heart failure device startup CardioKinetix should have ample funding to wrap up a pivotal clinical trial that’ll allow it to receive pre-market approval from the FDA: It just raised $50 million in financing, led by Edwards Lifesciences Corp. – which also scooped up exclusive rights to acquire CardioKinetix based on future regulatory milestones. Menlo Park-based CardioKinetix has […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Novartis could be on the verge of its next blockbuster. The Swiss pharma giant’s new heart failure drug could prove to replace the current standard of therapy, the company announced Saturday. A wide-spanning heart failure study found that Novartis’ drug candidate LCZ696 cut cardiovascular deaths by 20 percent when compared to ACE-inhibitors, which have been the go-to heart failure treatment […]
A company that has created a unique new therapy for patients with advanced heart failure is hoping to spread the word about its product in 2014, after a year of clinical trials in both Europe and the United States. Sunshine Heart, based in Eden Prairie, MN, raised more than $61 million in 2013, after two […]
An artificial heart maker in Tucson, Ariz., has raised $14 million to go small with its temporary Total Artificial Heart. Syncardia wants to build a 50cc version of the device. SWK Holdings Corporation contributed $10 million to this round. SWK is a publicly traded, specialized finance company with a focus on the global healthcare sector. […]
Eighty-five percent of healthcare executives in a new survey said their organization’s business plan addresses the CMS penalty for 30-day readmissions, and there are a few particular strategies many of them seem to be using. HealthLeaders Media asked 106 health system CEOs and physicians at 75 hospitals how their organizations are dealing with the reimbursement […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
CVRx, a Minneapolis-based firm that has developed proprietary implantable technology for the treatment of high blood pressure and heart failure, has raised $29.6 million for advancing clinical trials of its Barostim Neo, as well as expanding commercial activities abroad. Johnson & Johnson Development Corp. and New Enterprise Associates, Inc. were the co-lead investors. According to […]